Clearmind Medicine, Inc. (CMND)
0.715
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.71
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Net Income (Quarterly) : -0.9073M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.9073M |
| April 30, 2026 | -2.048M |
| January 31, 2026 | -3.855M |
| October 31, 2025 | -0.6878M |
| July 31, 2025 | -1.314M |
| April 30, 2025 | -0.7839M |
| January 31, 2025 | -1.072M |
| October 31, 2024 | -0.8847M |
| July 31, 2024 | -2.094M |
| April 30, 2024 | -0.9082M |
| January 31, 2024 | -1.368M |
| October 31, 2023 | -4.070M |
| July 31, 2023 | -0.5752M |
| April 30, 2023 | -2.076M |
| January 31, 2023 | -1.900M |
| October 31, 2022 | -1.594M |
| July 31, 2022 | -1.573M |
| April 30, 2022 | -2.506M |
| Date | Value |
|---|---|
| January 31, 2022 | -1.651M |
| October 31, 2021 | -2.012M |
| July 31, 2021 | -0.8808M |
| April 30, 2021 | -0.15M |
| January 31, 2021 | -0.0766M |
| October 31, 2020 | -0.0568M |
| July 31, 2020 | -0.0523M |
| April 30, 2020 | -0.0448M |
| January 31, 2020 | -0.0189M |
| October 31, 2019 | -0.0189M |
| July 31, 2019 | -0.0163M |
| April 30, 2019 | -0.0274M |
| January 31, 2019 | -0.0167M |
| October 31, 2018 | -0.1081M |
| July 31, 2018 | -0.0148M |
| April 30, 2018 | -0.0039M |
| January 31, 2018 | -0.0233M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -4.843M |
| NervGen Pharma Corp. | -21.10M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
| Lexaria Bioscience Corp. | -1.993M |
| Target Group, Inc. (Canada) | -0.2398M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.9073M |
| EPS Diluted (Quarterly) | -0.5734 |
| Enterprise Value | -12.60M |
| Earnings Yield | -12.33K% |
| Normalized Earnings Yield | -17013.13 |